Proinflammatory Effects of Calprotectin in Graves’ Orbitopathy

References

• McLachlan SM, Prummel MF, Rapoport B. Cell-mediated or humoral immunity in Graves’ ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab. 1994;78:1070–1074. doi:10.1210/jcem.78.5.8175962.
   PubMed Web of Science ®Google Scholar
• Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362:726–738. doi:10.1056/NEJMra0905750.
   PubMed Web of Science ®Google Scholar
• Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006;(72):1622–1631. doi:10.1016/j.bcp.2006.05.017.
   PubMed Web of Science ®Google Scholar
• Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med. 2013;13:24–57.
   PubMed Web of Science ®Google Scholar
• Roth J, Burwinkel F, van Den Bos C, Goebeler M, Vollmer E, Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood. 1993;82:1875–83.
   Web of Science ®Google Scholar
• Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta. 2004;344:37–51. doi:10.1016/j.cccn.2004.02.023.
   PubMed Web of Science ®Google Scholar
• Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol. 2003;170:3233–3242.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–285. doi:10.1530/EJE-07-0666.
   PubMed Web of Science ®Google Scholar
• Kuruto R, Nozawa R, Takeishi K, Arai K, Yokota T, Takasaki Y. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J Biochem. 1990;108:650–653.
   PubMed Web of Science ®Google Scholar
• Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9–14.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Pruenster M, Vogl T, Roth J, Sperandio M. S100A8/A9: from basic science to clinical application. Pharmacol Ther. 2016;167:120–131. doi:10.1016/j.pharmthera.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Choi IY, Gerlag DM, Herenius MJ, et al. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74:499–505. doi:10.1136/annrheumdis-2013-203923.
   PubMed Web of Science ®Google Scholar
• Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol. 2009;36:2190–2194. doi:10.3899/jrheum.081302.
   PubMed Web of Science ®Google Scholar
• Nistala K, Varsani H, Wittkowski H, et al. Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis. Arthritis Res Ther. 2013;15:R131. doi:10.1186/ar4311.
   PubMed Web of Science ®Google Scholar
• Xu X, Wu WY, Tu WZ, et al. Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. Clin Rheumatol. 2013;32:1501–1510. doi:10.1007/s10067-013-2305-4.
   PubMed Web of Science ®Google Scholar
• Korkmaz H, Tabur S, Savas E, et al. Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases. Balkan Med J. 2016;33:547–551. doi:10.5152/balkanmedj.2016.15881.
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Yang D, Bednarczuk T, Miyake I, Nonaka K, Inoue Y. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2000;85:1194–1199. doi:10.1210/jcem.85.3.6433.
   PubMed Web of Science ®Google Scholar
• Gu LQ, Jia HY, Zhao YJ, et al. Association studies of interleukin-8 gene in Graves’ disease and Graves’ ophthalmopathy. Endocrine. 2009;36:452–456. doi:10.1007/s12020-009-9240-9.
   PubMed Web of Science ®Google Scholar
• Hwang CJ, Afifiyan N, Sand D, et al. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci. 2009;50:2262–2268. doi:10.1167/iovs.08-2328.
   PubMed Web of Science ®Google Scholar
• Sunahori K, Yamamura M, Yamana J, et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther. 2006;8:R69. doi:10.1186/ar2087.
   PubMed Web of Science ®Google Scholar
• Pruenster M, Kurz AR, Chung KJ, et al. Extracellular MRP8/14 is a regulator of beta2 integrin-dependent neutrophil slow rolling and adhesion. Nat Commun. 2015;6:6915. doi: 10.1038/ncomms7915.
   Google Scholar
• Petersen B, Wolf M, Austermann J, et al. The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis. Embo J. 2013;32:100–111. doi:10.1038/emboj.2012.309.
   PubMed Web of Science ®Google Scholar
• Loser K, Vogl T, Voskort M, et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med. 2010;16:713–717. doi:10.1038/nm.2150.
   PubMed Web of Science ®Google Scholar
• Wu Y, Li Y, Zhang C, et al. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury. Hypertension. 2014;63:1241–1250. doi:10.1161/HYPERTENSIONAHA.113.02843.
   PubMed Web of Science ®Google Scholar
• Gao H, Hou J, Meng H, Zhang X, Zheng Y, Peng L. Proinflammatory effects and mechanisms of calprotectin on human gingival fibroblasts. J Periodontal Res. 2017;52:975–983. doi:10.1111/jre.12465.
   PubMed Web of Science ®Google Scholar
• Zhong A, Xu W, Zhao J, et al. S100A8 and S100A9 are induced by decreased hydration in the epidermis and promote fibroblast activation and fibrosis in the dermis. Am J Pathol. 2016;186:109–122. doi:10.1016/j.ajpath.2015.09.005.
   PubMed Web of Science ®Google Scholar
• Zhao LQ, Wei RL, Cheng JW, Cai JP, Li Y. The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves’ ophthalmopathy. Invest Ophthalmol Vis Sci. 2010;51:4652–4660. doi:10.1167/iovs.09-3789.
   PubMed Web of Science ®Google Scholar
• Sempowski GD, Rozenblit J, Smith TJ, Phipps RP. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 1998;274:C707–714.
   PubMed Web of Science ®Google Scholar
• Austermann J, Friesenhagen J, Fassl SK, et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. 2014;9:2112–2123. doi:10.1016/j.celrep.2014.11.020.
   PubMed Web of Science ®Google Scholar
• Volz HC, Laohachewin D, Seidel C, et al. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Res Cardiol. 2012;107:250. doi:10.1007/s00395-012-0250-z.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hou J, Peng L, et al. The pro-apoptotic and pro-inflammatory effects of calprotectin on human periodontal ligament cells. PLoS One. 2014;9:e110421. doi:10.1371/journal.pone.0110421.
   PubMed Web of Science ®Google Scholar
• Kang JH, Hwang SM, Chung IY. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-kappaB pathways. Immunology. 2015;144:79–90. doi:10.1111/imm.12352.
   PubMed Web of Science ®Google Scholar
• Bjork P, Bjork A, Vogl T, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009;7:e97. doi:10.1371/journal.pbio.1000097.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang F, Wang Y. S100A proteins in the pathogenesis of experimental corneal neovascularization. Mol Vis. 2010;16:2225–2235.
   PubMed Web of Science ®Google Scholar